Arsenic as leukemia therapy
|
U.S. Biopharma Cephalon named early inductee in “Global Growth” group.
|
Barr raises Pliva offer; Cephalon’s Fentora close to approval; Ketek gets a warning.
|
Naltrexone helps alcoholics sober up; Generic drugs to become $48B industry; Bone marrow drug approved.
|
FDA gives conditional approval to Vivitrol drug for treating alcohol dependency.
|
The two drug makers settle a patent dispute over a sleep drug, sending Cephalon’s shares up 5 percent.
|
Cephalon bids $360M for Zeneus; J&J still wants Guidant; Inamed’s board favors bid by Allergan.
|
New research shows that Americans are taking more sleeping medications than ever.
|
Aberdare buoys its coffers with a $150-million third fund.
|
New research reveals the mechanism behind many elderly deaths during sleep.
|